![]() |
|
|
Vol. 19, Issue 1, 86-94, January 2008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stabilization in Nonhypoxic Conditions: Role of Oxidation and Intracellular Ascorbate Depletion


*Centre de recherche de L'Hôtel-Dieu de Québec, Department of Medicine, Université Laval, Québec, QC, G1R 2J6, Canada;
Center for Clinical Science Research, Department of Radiation Oncology, Stanford University, Stanford, CA 94305; and
Molecular and Clinical Nutrition Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892
Submitted June 27, 2007;
Revised September 18, 2007;
Accepted October 10, 2007
Monitoring Editor: J. Silvio Gutkind
Hypoxia-inducible factor-1 (HIF-1) is a decisive element for the transcriptional regulation of many genes induced under low oxygen conditions. Under normal oxygen conditions, HIF-1
, the active subunit of HIF-1, is hydroxylated on proline residues by specific HIF prolyl-hydroxylases, leading to ubiquitination and degradation by the proteasome. In hypoxia, hydroxylation and ubiquitination are blocked and HIF-1
accumulates in cells. Recent studies have shown that in normal oxygen conditions G-protein–coupled receptor agonists, including angiotensin (Ang) II and thrombin, potently induce and activate HIF-1 in vascular smooth muscle cells. The current study identifies HIF-1
protein stabilization as a key mechanism for HIF-1 induction by Ang II. We show that hydroxylation on proline 402 is altered by Ang II, decreasing pVHL binding to HIF-1
and allowing HIF-1
protein to escape subsequent ubiquitination and degradation mechanisms. We show that HIF-1
stability is mediated through the Ang II–mediated generation of hydrogen peroxide and a subsequent decrease in ascorbate levels, leading to decreased HIF prolyl-hydroxylase activity and HIF-1
stabilization. These findings identify novel and intricate signaling mechanisms involved in HIF-1 complex activation and will lead to the elucidation of the importance of HIF-1 in different Ang II–related cell responses.
Address correspondence to: Darren E. Richard (darren.richard{at}crhdq.ulaval.ca)
Abbreviations used: Ang II, angiotensin II; HIF, hypoxia-inducible factor; HRE, hypoxic response element; GPCR, G-protein–coupled receptor; ODDD, oxygen-dependent degradation domain; PHD, HIF prolyl-hydroxylases; pVHL, von Hippel-Lindau protein; ROS, reactive oxygen species; VEGF, vascular endothelial growth factor; VSMCs, vascular smooth muscle cells.
This article has been cited by other articles:
![]() |
S. Barth, F. Edlich, U. Berchner-Pfannschmidt, S. Gneuss, G. Jahreis, P. A. Hasgall, J. Fandrey, R. H. Wenger, and G. Camenisch Hypoxia-inducible Factor Prolyl-4-hydroxylase PHD2 Protein Abundance Depends on Integral Membrane Anchoring of FKBP38 J. Biol. Chem., August 21, 2009; 284(34): 23046 - 23058. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Guo, G. Scicli, J. Sheng, J. C. Falck, P. A. Edwards, and A. G. Scicli 20-HETE can act as a nonhypoxic regulator of HIF-1{alpha} in human microvascular endothelial cells Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H602 - H613. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Michaud, G. A. Robitaille, J.-P. Gratton, and D. E. Richard Sphingosine-1-Phosphate: A Novel Nonhypoxic Activator of Hypoxia-Inducible Factor-1 in Vascular Cells Arterioscler Thromb Vasc Biol, June 1, 2009; 29(6): 902 - 908. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. N. Milovanova, V. M. Bhopale, E. M. Sorokina, J. S. Moore, T. K. Hunt, M. Hauer-Jensen, O. C. Velazquez, and S. R. Thom Hyperbaric oxygen stimulates vasculogenic stem cell growth and differentiation in vivo J Appl Physiol, February 1, 2009; 106(2): 711 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Qutub and A. S. Popel Reactive Oxygen Species Regulate Hypoxia-Inducible Factor 1{alpha} Differentially in Cancer and Ischemia Mol. Cell. Biol., August 15, 2008; 28(16): 5106 - 5119. [Abstract] [Full Text] [PDF] |
||||